Blood cancer is a life-changing diagnosis that can affect far more than a person’s physical health. It can influence energy levels, emotional well-being, relationships, sexual function, financial security, and the ability to plan.
Unlike cancers that begin as solid tumors in organs such as the breast, lung, or colon, blood cancers affect the blood-forming tissues, bone marrow, lymphatic system, or cells that help the body fight infection. Some develop rapidly and require immediate treatment, while others progress slowly and may be monitored for a period of time before treatment begins.
Advances in cancer research have created more treatment options for many blood cancers, including targeted therapies, immunotherapy, cellular therapies, and stem cell transplantation. However, treatment can be physically demanding, and some people experience long-term effects even after their cancer is in remission.
Understanding blood cancer, recognizing its symptoms, and learning how it may affect daily life can help patients and their loved ones prepare for the journey ahead.
What Is Blood Cancer?
Blood cancer, also called hematologic cancer, is a broad term for cancers that begin in blood-forming tissues, immune cells, or the lymphatic system.
Normally, the bone marrow produces red blood cells, white blood cells, and platelets. These cells perform essential functions:
- Red blood cells carry oxygen throughout the body.
- White blood cells help protect against infections.
- Platelets help blood clot and prevent excessive bleeding.
Blood cancers develop when abnormal cells grow uncontrollably and interfere with the production or function of healthy cells. Depending on the cancer type, abnormal cells may accumulate in the bone marrow, circulate through the bloodstream, collect in lymph nodes, or affect other organs.
There are many different blood cancers, and they do not all behave the same way. Some grow aggressively, while others may remain stable for years.
The Major Types of Blood Cancer
Leukemia
Leukemia begins in blood-forming tissues, usually bone marrow, and affects the development of blood cells.
Abnormal cells can crowd out healthy cells, making it difficult for the body to fight infections, carry oxygen, or control bleeding.
The major types include:
- Acute lymphoblastic leukemia (ALL): Often develops rapidly and requires prompt treatment. It occurs in children and adults.
- Acute myeloid leukemia (AML): An aggressive leukemia that usually requires urgent evaluation and treatment.
- Chronic lymphocytic leukemia (CLL): Often progresses slowly. Some patients can be monitored without immediate treatment.
- Chronic myeloid leukemia (CML): Frequently managed with targeted medications that inhibit the abnormal protein driving the disease.
The differences between these leukemias matter because their treatments, expected courses, and long-term outcomes can vary considerably.
Lymphoma
Lymphoma begins in lymphocytes, a type of white blood cell involved in the immune system. It commonly affects lymph nodes but can also involve other organs.
The two main categories are:
- Hodgkin lymphoma: Often highly treatable, including in many advanced-stage cases.
- Non-Hodgkin lymphoma: A diverse group of cancers that includes both slow-growing and aggressive forms.
Symptoms may include enlarged lymph nodes, persistent fatigue, unexplained fever, night sweats, and unintended weight loss.
Some lymphomas can be cured, while others may require ongoing treatment or management over time.
Multiple Myeloma
Multiple myeloma develops from plasma cells, which normally produce antibodies to help fight infections.
Abnormal plasma cells accumulate in the bone marrow and may damage bones, impair kidney function, and interfere with healthy blood cell production.
Possible symptoms include bone pain, fractures, fatigue, frequent infections, anemia, and kidney problems.
Multiple myeloma is generally considered treatable but not curable with current standard therapies. Some patients achieve prolonged remissions, and newer treatments continue to improve disease control.
Other Blood Cancers and Bone Marrow Disorders
Other blood-related cancers include myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), and certain plasma cell or lymphoid disorders.
Some are chronic conditions that require monitoring and symptom management. Others can progress or transform into more aggressive cancers.
Because the term blood cancer includes so many diseases, a treatment plan or prognosis for one type should not be applied automatically to another.
Blood Cancer Awareness Month: Why It Matters
Blood Cancer Awareness Month is observed every September. It is an opportunity to educate the public, encourage people to seek medical evaluation for persistent symptoms, support patients and caregivers, and raise awareness of research and treatment advances.
Awareness is important because blood cancer symptoms can resemble those of common illnesses. Fatigue may be attributed to stress, bruising may seem insignificant, and swollen lymph nodes may be mistaken for a routine infection.
There is no universal screening test recommended for the general population for all blood cancers. Recognizing persistent or unexplained changes and seeking appropriate medical evaluation are therefore important.
Awareness also means understanding that blood cancer does not affect every person in the same way. One person may receive intensive treatment immediately, while another may live with a slowly progressing cancer that requires monitoring.
For patients and families, awareness can reduce isolation, improve understanding of treatment decisions, and encourage conversations about the physical and emotional challenges that often accompany diagnosis.
Symptoms and Warning Signs of Blood Cancer
Blood cancer symptoms vary according to the type of disease, how quickly it develops, and which parts of the body are affected.
Some people experience several symptoms before diagnosis, while others discover the disease through routine blood work.
Common Symptoms
Persistent fatigue and weakness
Fatigue can occur when the bone marrow produces too few healthy red blood cells, resulting in anemia. People may feel exhausted despite adequate rest or struggle with everyday activities that previously seemed easy.
Frequent or persistent infections
Abnormal white blood cells may not function properly, even when their numbers appear high. Some blood cancers and their treatments weaken the immune system, making infections more frequent or severe.
Easy bruising or bleeding
Low platelet counts can lead to unexplained bruises, frequent nosebleeds, bleeding gums, or prolonged bleeding from minor injuries.
Unexplained fever and night sweats
Some blood cancers cause persistent fever or drenching night sweats that soak clothing or bedding. These symptoms can also occur with infections and other medical conditions.
Swollen lymph nodes
Lymphoma and some leukemias can cause enlarged lymph nodes in the neck, armpits, groin, or other areas. Swollen lymph nodes are often caused by infections, but persistent or unexplained swelling should be evaluated.
Unintentional weight loss or reduced appetite
Some patients lose weight without trying. Changes in metabolism, inflammation, illness, or treatment effects may contribute.
Bone or joint pain
Bone pain can occur when abnormal cells accumulate in the marrow. It is particularly relevant in multiple myeloma but can occur in other blood cancers.
Shortness of breath, dizziness, or pale skin
These symptoms may result from anemia or other complications.
Abdominal fullness or discomfort
Some blood cancers cause enlargement of the spleen or liver, which can create pressure, discomfort, or a feeling of fullness after eating small amounts.
Not everyone with these symptoms has cancer. Many have more common explanations. However, symptoms that persist, worsen, or occur without a clear cause deserve medical attention.
Seek urgent medical care for severe shortness of breath, uncontrolled bleeding, sudden confusion, or other severe symptoms. People undergoing treatment should follow their oncology team’s instructions for fever and possible infection, because these can become medical emergencies when immune defenses are low.
How Is Blood Cancer Diagnosed?
Diagnosis usually involves several tests, depending on the suspected disease.
These may include:
- Complete blood count and other blood tests.
- Examination of blood cells under a microscope.
- Bone marrow aspiration or biopsy.
- Lymph node biopsy for suspected lymphoma.
- Flow cytometry to identify specific cell types.
- Genetic and molecular testing to identify changes that help classify the cancer and guide treatment.
- Imaging studies when needed to evaluate lymph nodes, organs, or other areas.
The results help determine the specific cancer subtype, its risk characteristics, and which treatments are most likely to help.
Molecular testing is particularly important in many blood cancers because certain genetic changes can guide the use of targeted medications.
Treatment Options for Blood Cancer
Treatment depends on the exact diagnosis, disease stage or risk category, genetic findings, overall health, and personal goals.
Some cancers require immediate treatment, while others may be safely monitored until there are signs of progression or the disease begins causing problems.
Chemotherapy
Chemotherapy uses medications to kill cancer cells or stop them from growing.
It remains an important treatment for many leukemias and lymphomas and may also be used in other blood cancers.
Depending on the diagnosis, chemotherapy may be given through an intravenous infusion, as an injection, or in pill form.
Potential side effects include:
- Fatigue and weakness.
- Nausea, vomiting, and appetite changes.
- Hair loss.
- Mouth sores and digestive problems.
- Low blood counts.
- Increased risk of infection and bleeding.
- Nerve damage or numbness.
- Changes in fertility or sexual function.
Not every patient experiences every side effect, and the severity depends on the drugs, doses, and individual circumstances.
Targeted Therapy
Targeted therapies act on specific proteins, enzymes, or genetic changes that help cancer cells survive and grow.
Examples include tyrosine kinase inhibitors used for CML and targeted medications used in selected cases of CLL, AML, lymphoma, and other blood cancers.
These treatments may be taken orally or administered in other forms, depending on the medication.
Targeted therapies have transformed care for certain blood cancers, allowing some patients to manage their disease for long periods. However, side effects can still occur, and ongoing monitoring is often necessary.
Immunotherapy
Immunotherapy helps the immune system recognize or attack cancer cells.
Approaches include monoclonal antibodies, immune checkpoint inhibitors in selected diseases, bispecific antibodies, and other immune-based treatments.
Some therapies recognize specific proteins on cancer cells and direct immune cells toward them. Others help the immune system overcome signals that suppress its activity.
Immunotherapy has become an important option for certain lymphomas, leukemias, and other blood cancers, but effectiveness varies by diagnosis.
Possible side effects range from infusion reactions and fatigue to serious immune-related complications. Some specialized immune therapies can cause cytokine release syndrome or neurological complications and require close monitoring.
CAR T-Cell Therapy
CAR T-cell therapy is a form of cellular immunotherapy in which a patient’s T cells are collected and modified so that they can recognize particular cancer-cell targets.
The modified cells are returned to the patient to attack the cancer.
CAR T-cell therapies are available for certain blood cancers, including selected leukemias, lymphomas, and multiple myeloma.
For eligible patients, these treatments can produce deep and sometimes long-lasting responses, even when other therapies have not worked.
However, CAR T-cell therapy is complex. It may cause cytokine release syndrome, neurological effects, prolonged low blood counts, or serious infections. Patients need specialized care and monitoring.
Stem Cell Transplantation
A blood or bone marrow stem cell transplant can be used for selected blood cancers.
The process involves high-dose treatment to eliminate cancer cells and, in some cases, replace diseased bone marrow with healthy blood-forming stem cells.
Stem cells may come from the patient or a donor, depending on the diagnosis and treatment plan.
Transplantation can offer a chance of long-term remission or cure in certain circumstances, but it also carries significant risks, including infection, organ complications, infertility, and, with donor transplants, graft-versus-host disease.
Recovery may take months or longer, and some effects can persist after the transplant.
Radiation Therapy
Radiation therapy uses targeted radiation to destroy cancer cells in a specific area.
It may be used for selected lymphomas, localized disease, symptom relief, or certain complications of blood cancers.
Unlike systemic treatments, radiation primarily treats the area being targeted. Side effects depend on the body region receiving radiation and may include fatigue, skin changes, and effects on nearby organs.
Active Surveillance and Supportive Care
Not every blood cancer requires immediate treatment. Some slow-growing diseases can be monitored with regular examinations and laboratory tests.
This approach is sometimes called active surveillance or watchful waiting. It does not mean that cancer is being ignored. It means treatment can be delayed until the expected benefits outweigh the risks.
Supportive care is also important throughout treatment. It may include blood transfusions, medications to prevent or treat infections, nutritional support, pain management, and rehabilitation.
Palliative care can help manage symptoms and emotional distress alongside cancer-directed treatment. It is not limited to end-of-life care.
Newer therapies continue to expand options, but their appropriateness depends on the specific cancer and the patient’s circumstances.
Citations.
Blood Cancer United
Cancer Care
Cancer.org
Empowering Intimacy